According to the presented results, IL-6 does not change the level of angiogenic factors in the MNC of MPN and HEL cells, as well as the phosphorylation of STAT5 and mTOR in HEL cells, while it slightly stimulated AKT signaling. The gene discussed is MTOR; the disease is myeloproliferative disorder.